FULC
Price
$3.96
Change
-$0.02 (-0.50%)
Updated
Jan 17 closing price
Capitalization
213.6M
40 days until earnings call
IMTX
Price
$5.35
Change
+$0.01 (+0.19%)
Updated
Jan 17 closing price
Capitalization
650.29M
60 days until earnings call
Ad is loading...

FULC vs IMTX

Header iconFULC vs IMTX Comparison
Open Charts FULC vs IMTXBanner chart's image
Fulcrum Therapeutics
Price$3.96
Change-$0.02 (-0.50%)
Volume$464.82K
Capitalization213.6M
Immatics
Price$5.35
Change+$0.01 (+0.19%)
Volume$1.06M
Capitalization650.29M
FULC vs IMTX Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. IMTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and IMTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (FULC: $3.96 vs. IMTX: $5.35)
Brand notoriety: FULC and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 48% vs. IMTX: 134%
Market capitalization -- FULC: $213.6M vs. IMTX: $650.29M
FULC [@Biotechnology] is valued at $213.6M. IMTX’s [@Biotechnology] market capitalization is $650.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 2 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 2 bullish, 6 bearish.
  • IMTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а -9.38% price change this week, while IMTX (@Biotechnology) price change was -16.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

FULC is expected to report earnings on May 19, 2025.

IMTX is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($650M) has a higher market cap than FULC($214M). FULC YTD gains are higher at: -15.745 vs. IMTX (-24.754). FULC has higher annual earnings (EBITDA): -26.67M vs. IMTX (-36.26M). IMTX has more cash in the bank: 491M vs. FULC (257M). FULC has less debt than IMTX: FULC (9.15M) vs IMTX (16M). IMTX has higher revenues than FULC: IMTX (116M) vs FULC (80.9M).
FULCIMTXFULC / IMTX
Capitalization214M650M33%
EBITDA-26.67M-36.26M74%
Gain YTD-15.745-24.75464%
P/E RatioN/AN/A-
Revenue80.9M116M70%
Total Cash257M491M52%
Total Debt9.15M16M57%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCIMTX
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
88%
Bullish Trend 11 days ago
76%
Momentum
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 11 days ago
74%
MACD
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
87%
Bearish Trend 11 days ago
74%
Advances
ODDS (%)
Bullish Trend 16 days ago
88%
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
78%
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMGCX17.190.19
+1.12%
Neuberger Berman Mid Cap Growth C
SAIEX11.110.07
+0.63%
Spirit of America Energy Institutional
LQFLX13.570.07
+0.52%
Lord Abbett Focused Large Cap Value R3
IHSFX23.450.09
+0.39%
Hartford Small Company F
PEIIX40.08N/A
N/A
Principal Equity Income Inst

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-0.50%
ONCT - FULC
55%
Loosely correlated
N/A
SLS - FULC
48%
Loosely correlated
+7.86%
ANNX - FULC
40%
Loosely correlated
+2.19%
VRDN - FULC
39%
Loosely correlated
+6.27%
NKTX - FULC
35%
Loosely correlated
-0.80%
More

IMTX and

Correlation & Price change

A.I.dvisor tells us that IMTX and RXRX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMTX and RXRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.19%
RXRX - IMTX
33%
Poorly correlated
+2.03%
ADMA - IMTX
33%
Poorly correlated
-3.67%
KRRO - IMTX
33%
Poorly correlated
+0.05%
FULC - IMTX
31%
Poorly correlated
-0.50%
MRUS - IMTX
31%
Poorly correlated
-0.50%
More